Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Orgovyx
Pharma
Sumitomo Pharma lays off 400 US staffers as sales slide
The company, which makes Myfembree, Gemtesa and Orgovyx, previously let go of 500 staffers last summer.
Zoey Becker
Mar 5, 2024 5:35pm
Myovant rejects Sumitomo's buyout offer—at least for now
Oct 3, 2022 11:04am
FDA knocks Myovant, Pfizer's NDA for Myfembree off track
Apr 12, 2022 9:31am
EMA expands nods for BMS, Eli Lilly, Novartis drugs
Feb 25, 2022 11:42am
Myovant leans on partner Pfizer as it dives into Orgovyx launch
Jan 25, 2021 3:15pm
